Target intelligence / Profile preview

Follicular granulosa cell apoptosis

Molecular classification
Other
01

Overview

Follicular granulosa cell apoptosis is a fundamental biological process characterized by the programmed cell death of granulosa cells within the ovarian follicle, primarily serving as the mechanism for follicular atresia [4, 11]. This process is tightly regulated by a balance of survival factors, such as follicle-stimulating hormone (FSH) and estrogen, and pro-apoptotic signals, including Caspase-3, BAX, and FoxO1 [6, 11, 13]. In a healthy ovary, more than 99% of follicles undergo atresia via this apoptotic pathway, ensuring that only a dominant follicle reaches ovulation in each cycle [12, 18]. Dysregulation of this process is a hallmark of major reproductive disorders: excessive apoptosis is a primary cause of premature ovarian failure (POF) and reproductive aging, while abnormally low levels of apoptosis contribute to the characteristic accumulation of small antral follicles in polycystic ovary syndrome (PCOS) [1, 6, 14]. Therapeutic interventions often target this pathway by utilizing gonadotropins (e.g., recombinant FSH) to promote survival signaling through the PI3K/Akt/mTOR pathway or by using antioxidants like resveratrol and vitamin E to mitigate oxidative stress-induced cell death [1, 10, 16]. Understanding and modulating granulosa cell apoptosis is therefore critical for managing infertility, enhancing the success of assisted reproductive technologies, and preserving ovarian function [2, 12, 13].

Other names
Granulosa cell apoptosisOvarian follicular atresiaGranulosa cell programmed cell deathGC apoptosis
02

Mechanism of action

Modulation of the intrinsic and extrinsic apoptotic pathways via activation of survival signaling (PI3K/Akt/mTOR), inhibition of executioner caspases (Caspase-3), and transcriptional regulation of BCL-2 family proteins and FoxO1.

03

Biological functions

ApoptosisOvarian follicular developmentSteroidogenesisCell deathTissue remodeling
04

Disease associations

Polycystic ovary syndromePremature ovarian failureInfertilityOvarian agingEndometriosis
05

Safety considerations

Ovarian hyperstimulation syndrome (OHSS)Potential risk of tumorigenesis due to inhibited apoptosisHormonal imbalances and endocrine disruptionImpact on oocyte quality
06

Interacting drugs

Follitropin alfa (Recombinant FSH)

5 more in the full profile.

07

Biomarkers

Anti-Müllerian hormone (AMH)Caspase-3Terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL)Reactive oxygen species (ROS)Bax/Bcl-2 ratio

Beyond the preview

Go deeper on Follicular granulosa cell apoptosis.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Follicular granulosa cell apoptosis.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call